This company has been acquired
Heska Past Earnings Performance
Past criteria checks 0/6
Heska's earnings have been declining at an average annual rate of -55.5%, while the Medical Equipment industry saw earnings growing at 10% annually. Revenues have been growing at an average rate of 19.4% per year.
Key information
-55.5%
Earnings growth rate
-52.6%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 19.4% |
| Return on equity | -4.8% |
| Net Margin | -7.9% |
| Last Earnings Update | 31 Mar 2023 |
Recent past performance updates
Recent updates
Is Heska Corporation (NASDAQ:HSKA) Potentially Undervalued?
Feb 09
Are Investors Undervaluing Heska Corporation (NASDAQ:HSKA) By 50%?
Jan 18Heska to acquire LightDeck Diagnostics for $38.7M
Sep 12Is Heska (NASDAQ:HSKA) A Risky Investment?
Sep 07Are Investors Undervaluing Heska Corporation (NASDAQ:HSKA) By 31%?
Aug 17Heska Non-GAAP EPS of $0.34 misses by $0.03, revenue of $64.7M misses by $3.76M
Aug 08Is Heska (NASDAQ:HSKA) A Risky Investment?
May 09Heska Corporation (NASDAQ:HSKA) Shares Could Be 50% Below Their Intrinsic Value Estimate
Apr 03What Is Heska Corporation's (NASDAQ:HSKA) Share Price Doing?
Mar 02Heska (NASDAQ:HSKA) Has A Rock Solid Balance Sheet
Jan 09Estimating The Fair Value Of Heska Corporation (NASDAQ:HSKA)
Dec 13What Does Heska Corporation's (NASDAQ:HSKA) Share Price Indicate?
Nov 17Is Heska (NASDAQ:HSKA) A Risky Investment?
Sep 28Is Heska Corporation (NASDAQ:HSKA) Potentially Undervalued?
Jul 21Is Heska (NASDAQ:HSKA) A Risky Investment?
Jun 29Calculating The Intrinsic Value Of Heska Corporation (NASDAQ:HSKA)
May 28Heska EPS beats by $0.69, beats on revenue
May 06Is Heska Corporation (NASDAQ:HSKA) Potentially Undervalued?
Apr 15How Much Are Heska Corporation (NASDAQ:HSKA) Insiders Taking Off The Table?
Mar 19A Look At The Fair Value Of Heska Corporation (NASDAQ:HSKA)
Feb 21
Revenue & Expenses BreakdownBeta
How Heska makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 23 | 255 | -20 | 113 | 20 |
| 31 Dec 22 | 257 | -20 | 112 | 20 |
| 30 Sep 22 | 259 | -16 | 100 | 9 |
| 30 Jun 22 | 258 | -18 | 105 | 9 |
| 31 Mar 22 | 258 | -13 | 104 | 8 |
| 31 Dec 21 | 254 | -1 | 100 | 7 |
| 30 Sep 21 | 250 | 2 | 92 | 8 |
| 30 Jun 21 | 246 | -1 | 93 | 8 |
| 31 Mar 21 | 227 | -7 | 85 | 8 |
| 31 Dec 20 | 197 | -14 | 74 | 9 |
| 30 Sep 20 | 167 | -19 | 70 | 8 |
| 30 Jun 20 | 141 | -14 | 53 | 8 |
| 31 Mar 20 | 124 | -8 | 46 | 9 |
| 31 Dec 19 | 123 | -1 | 45 | 8 |
| 30 Sep 19 | 123 | 4 | 37 | 7 |
| 30 Jun 19 | 123 | 2 | 43 | 6 |
| 31 Mar 19 | 124 | 5 | 43 | 4 |
| 31 Dec 18 | 127 | 6 | 50 | 3 |
| 30 Sep 18 | 129 | 1 | 48 | 3 |
| 30 Jun 18 | 129 | 6 | 39 | 2 |
| 31 Mar 18 | 133 | 8 | 39 | 2 |
| 31 Dec 17 | 129 | 10 | 38 | 2 |
| 30 Sep 17 | 133 | 14 | 38 | 2 |
| 30 Jun 17 | 136 | 15 | 38 | 2 |
| 31 Mar 17 | 132 | 14 | 36 | 2 |
| 31 Dec 16 | 130 | 11 | 35 | 2 |
| 30 Sep 16 | 120 | 9 | 35 | 2 |
| 30 Jun 16 | 115 | 7 | 34 | 2 |
| 31 Mar 16 | 109 | 6 | 33 | 2 |
| 31 Dec 15 | 105 | 5 | 34 | 2 |
| 30 Sep 15 | 99 | 4 | 33 | 2 |
| 30 Jun 15 | 93 | 3 | 32 | 1 |
| 31 Mar 15 | 92 | 3 | 32 | 1 |
| 31 Dec 14 | 90 | 3 | 31 | 1 |
| 30 Sep 14 | 89 | 3 | 31 | 1 |
| 30 Jun 14 | 85 | 3 | 30 | 1 |
| 31 Mar 14 | 80 | -1 | 30 | 1 |
| 31 Dec 13 | 78 | -1 | 31 | 2 |
| 30 Sep 13 | 73 | -2 | 30 | 1 |
| 30 Jun 13 | 73 | -2 | 29 | 1 |
| 31 Mar 13 | 73 | 0 | 29 | 1 |
| 31 Dec 12 | 73 | 1 | 28 | 1 |
| 30 Sep 12 | 70 | 1 | 27 | 1 |
| 30 Jun 12 | 71 | 2 | 27 | 1 |
Quality Earnings: HSKA is currently unprofitable.
Growing Profit Margin: HSKA is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: HSKA is unprofitable, and losses have increased over the past 5 years at a rate of 55.5% per year.
Accelerating Growth: Unable to compare HSKA's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: HSKA is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (1.5%).
Return on Equity
High ROE: HSKA has a negative Return on Equity (-4.8%), as it is currently unprofitable.